Insmed (INSM) Income from Continuing Operations (2010 - 2026)

Insmed (INSM) recorded quarterly Income from Continuing Operations of 163563000.0 in Q1 2026, up 50.21% quarter-over-quarter from 328485000.0 in Q4 2025, and up 36.25% on a YoY basis from 120045890.84 in Q1 2025.

Insmed (INSM) Income from Continuing Operations (2010 - 2026) Analysis & Trends

Insmed's Income from Continuing Operations history runs 17 years deep, the most recent figure standing at 163563000.0 for Q1 2026.

  • In Q1 2026, Income from Continuing Operations rose 36.25% year-over-year to 163563000.0; the TTM figure through Mar 2026 stood at 1183735000.0 (down 16.82% YoY), while the FY2025 annual figure was 1276775000.0, down 39.73% from the prior year.
  • Income from Continuing Operations was 163563000.0 for Q1 2026 at Insmed, up from 328485000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 94621000.0 in Q1 2022 to a low of 370001000.0 in Q3 2025.
  • Historically, Income from Continuing Operations has averaged 210893352.94 across 5 years, with a median of 186063000.0 in 2023.
  • The sharpest annual moves came in 2023 and 2026: Income from Continuing Operations sank 155.96% in 2023, then jumped 36.25% in 2026.
  • A 5-year view of Income from Continuing Operations shows it stood at 160081000.0 in 2022, then retreated by 16.23% to 186063000.0 in 2023, then fell by 26.61% to 235582000.0 in 2024, then slumped by 39.44% to 328485000.0 in 2025, then surged by 50.21% to 163563000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 163563000.0 (Q1 2026), 328485000.0 (Q4 2025), and 370001000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - -
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - -2.97 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - -14.46 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - -3.40 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 1.03 Bn
9 Abivax 95.45 Bn 95.45 Bn - -56.48 Mn
10 Insmed 21.32 Bn 20.09 Bn 258.54 Mn -163.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -163.56 Mn
Dec 31, 2025 -328.49 Mn
Sep 30, 2025 -370.00 Mn
Jun 30, 2025 -321.69 Mn
Mar 31, 2025 -256.57 Mn
Dec 31, 2024 -235.58 Mn
Sep 30, 2024 -220.51 Mn
Jun 30, 2024 -300.61 Mn
Mar 31, 2024 -157.09 Mn
Dec 31, 2023 -186.06 Mn
Sep 30, 2023 -158.93 Mn
Jun 30, 2023 -244.81 Mn
Mar 31, 2023 -159.76 Mn
Dec 31, 2022 -160.08 Mn
Sep 30, 2022 -131.17 Mn
Jun 30, 2022 -95.65 Mn
Mar 31, 2022 -94.62 Mn
Dec 31, 2021 -112.94 Mn
Sep 30, 2021 -112.71 Mn
Jun 30, 2021 -117.30 Mn